Antihypertensive medication Covid-19 hospitalization in total population Covid-19 hospitalization in total population 28-day mortality in Covid-19 patients 28-day mortality in Covid-19 patients 28-day mortality in Covid-19 patients 28-day mortality in hospitalized Covid-19 patients 28-day mortality in hospitalized Covid-19 patients
ntotal ncase OR (95%CI) * OR (95%CI) * OR (95%CI) * ntotal ncase ncase OR (95%CI) * OR (95%CI) * ntotal ncase OR (95%CI) * OR (95%CI) * OR (95%CI) *
Simple model* Simple model* Full model Simple model* Full model Simple model* Simple model* Full model
ARB 31917 264 Ref. Ref. Ref. 1217 100 100 Ref. Ref. 264 58 Ref. Ref. Ref.
CCB 44816 345 0.91 (0.78-1.07) 0.91 (0.78-1.07) 1.09 (0.93-1.29) 1694 99 99 0.68 (0.50-0.91) 0.74 (0.54-1.02) 345 74 0.91 (0.61-1.36) 0.91 (0.61-1.36) 1.02 (0.65-1.59)
ARB 31917 264 Ref. Ref. Ref. 1217 100 100 Ref. Ref. 264 58 Ref. Ref. Ref.
BB 24550 305 1.45 (1.23-1.72) 1.45 (1.23-1.72) 1.26 (1.06-1.49) 968 115 115 1.19 (0.89-1.60) 1.07 (0.78-1.47) 305 76 0.98 (0.65-1.47) 0.98 (0.65-1.47) 1.04 (0.66-1.64)
ARB 31917 264 Ref. Ref. Ref. 1217 100 100 Ref. Ref. 264 58 Ref. Ref. Ref.
Diuretic 23286 297 1.54 (1.31-1.83) 1.54 (1.31-1.83) 1.28 (1.08-1.52) 922 109 109 1.26 (0.93-1.69) 1.03 (0.75-1.42) 297 76 1.11 (0.74-1.66) 1.11 (0.74-1.66) 1.05 (0.67-1.64)
ARB 31917 264 Ref. Ref. Ref. 1217 100 100 Ref. Ref. 264 58 Ref. Ref. Ref.
CCB/BB/Diuretic 38691 366 1.15 (0.98-1.35) 1.15 (0.98-1.35) 1.50 (1.27-1.77) 1485 137 137 1.06 (0.80-1.41) 1.18 (0.87-1.59) 366 90 1.06 (0.72-1.56) 1.06 (0.72-1.56) 1.25 (0.80-1.94)